Deferoxamine enhances cell migration and invasion through promotion of HIF-1α expression and epithelial-mesenchymal transition in colorectal cancer

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 111-116

  Zhang, Wenjing ^a   Wu, Yao ^a   Yan, Qingqing ^a   Ma, Feng ^a   Shi, Xinpeng ^a   Zhao, Yingying ^a   Peng, Ying ^a   Wang, Jide ^a   Jiang, Bo ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Deferoxamine; Epithelial mesenchymal transition; Hypoxia inducible factor 1

Indexed keywords

DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NERVE CELL ADHESION MOLECULE; PLAKOGLOBIN; UVOMORULIN; VIMENTIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL HYPOXIA; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL STRAIN HCT116; CELL STRAIN HT29; CELL STRUCTURE; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; METASTASIS; PRIORITY JOURNAL; SPINDLE CELL;

CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DEFEROXAMINE; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; GAMMA CATENIN; HCT116 CELLS; HT29 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SIDEROPHORES; SIGNAL TRANSDUCTION; VIMENTIN; WOUND HEALING;

EID: 84891948851     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2828     Document Type: Article

References (32)

1. Kalinowski DS and Richardson DR: The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev 57: 547-583, 2005.
2. Mantovani A, Evans R and Alexander P: Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas. Br J Cancer 36: 35-40, 1977.
3. Boult J, Roberts K, Brookes MJ, et al: Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma. Clin Cancer Res 14: 379-387, 2008.
4. Miller LD, Coffman LG, Chou JW, et al: An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res 71: 6728-6737, 2011.
5. Follézou JY and Bizon M: Cancer chemotherapy induces a transient increase of serum-iron level. Neoplasma 33: 225-231, 1986.
6. Yu Y, Gutierrez E, Kovacevic Z, et al: Iron chelators for the treatment of cancer. Curr Med Chem 19: 2689-2702, 2012.
7. Recalcati S, Locati M, Gammella E, Invernizzi P and Cairo G: Iron levels in polarized macrophages: regulation of immunity and autoimmunity. Autoimmun Rev 11: 883-889, 2012.
8. Kaczmarek M, Cachau RE, Topol IA, Kasprzak KS, Ghio A and Salnikow K: Metal ions stimulated iron oxidation in hydroxylases facilitates stabilization of HIF-1α protein. Toxicol Sci 107: 394-403, 2009.
9. Martínez-Romero R, Martínez-Lara E, Aguilar-Quesada R, Peralta A, Oliver FJ and Siles E: PARP-1 modulates deferoxamine-induced HIF-1α accumulation through the regulation of nitric oxide and oxidative stress. J Cell Biochem 104: 2248-2260, 2008.
10. Yang Y, Sun M, Wang L and Jiao B: HIFs, angiogenesis, and cancer. J Cell Biochem 114: 967-974, 2013.
11. Simiantonaki N, Taxeidis M, Jayasinghe C, Kurzik-Dumke U and Kirkpatrick C: Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer 8: 320, 2008.
12. Semenza GL: Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35: 71-103, 2000.
13. Vincent-Salomon A and Thiery JP: Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 5: 101-106, 2003.
14. Zhang W, Jiang B, Guo Z, et al: Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer. Carcinogenesis 31: 1220-1229, 2010.
15. Zhang W, Wang J, Zou B, et al: Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1. Eur J Cancer 47: 121-130, 2011.
16. Kahlert UD, Nikkhah G and Maciaczyk J: Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett 331: 131-138, 2013.
17. Roy N, Bommi PV, Bhat UG, et al: DDB2 suppresses epithelial-to- mesenchymal transition in colon cancer. Cancer Res 73: 3771-3782, 2013.
18. Higgins DF, Kimura K, Bernhardt WM, et al: Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117: 3810-3820, 2007.
19. Jiang J, Tang YL and Liang XH: EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther 11: 714-723, 2011.
20. Yang MH, Wu MZ, Chiou SH, et al: Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol 10: 295-305, 2008.
21. Zhang Q, Bai X, Chen W, et al: Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. Carcinogenesis 34: 962-973, 2013.
22. Wang J, Yang Y, Xia HH, et al: Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. Gastroenterology 132: 1066-1076, 2007.
23. Hollestelle A, Peeters JK, Smid M, et al: Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer. Breast Cancer Res Treat 138: 47-57, 2013.
24. Lester BR and McCarthy JB: Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev 11: 31-44, 1992.
25. Bartolazzi A, Cerboni C, Nicotra MR, Mottolese M, Bigotti A and Natali PG: Transformation and tumor progression are frequently associated with expression of the alpha 3/beta 1 heterodimer in solid tumors. Int J Cancer 58: 488-491, 1994.
26. Wei L, Yang Y, Zhang X and Yu Q: Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 23: 9052-9061, 2004.
27. Zheng Y, Ni Y, Huang X, Wang Z and Han W: Overexpression of HIF-1α indicates a poor prognosis in tongue carcinoma and may be associated with tumour metastasis. Oncol Lett 5: 1285-1289, 2013.
28. Cheli Y, Giuliano S, Fenouille N, et al: Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 31: 2461-2470, 2012.
29. Martinez-Outschoorn UE, Trimmer C, Lin Z, et al: Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment. Cell Cycle 9: 3515-3533, 2010.
30. Tanaka T and Nangaku M: Angiogenesis and hypoxia in the kidney. Nat Rev Nephrol 9: 211-222, 2013.
31. Haddad JJ, Olver RE and Land SC: Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem 275: 21130-21139, 2000.
32. Schmalhofer O, Brabletz S and Brabletz T: E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28: 151-166, 2009.